Rocket


Overview
Financials
News + Filings
Key Docs
Ownership
Insiders

Insiders Menu
Roster
Transactions
Taysha Gene Therapies, Inc.

DateNameTitleTypeSecuritySharesPriceValueOwnershipReported
08/24/2023Alam KamranCFOSaleCommon Stock33k$2.33$76.9k 08/24/2023
08/16/2023Stalfort John A IIIDirectorPurchaseCommon Stock388.9k$0.90$350kSee footnote08/16/2023
08/16/2023Manning Paul B10% OwnerPurchaseCommon Stock16.5M$0.90$14.8MSee footnote08/16/2023
08/16/2023Stalfort John A IIIDirectorPurchaseCommon Stock388.9k$0.90$350k 08/16/2023
08/16/2023Stalfort John A IIIDirectorGiftCommon Stock50k$0.00$0 08/16/2023
08/16/2023Donenberg Phillip B.DirectorPurchaseCommon Stock111.1k$0.90$100k 08/16/2023
08/16/2023Nolan Sean P.CEOPurchaseCommon Stock444.4k$0.90$400kSee Footnote08/16/2023
07/13/2023Session R.A. II10% OwnerSaleCommon Stock5.3k$0.70$3.7k 07/12/2023
07/12/2023Session R.A. II10% OwnerSaleCommon Stock80.5k$0.71$57k 07/12/2023
05/16/2023Nagendran SukumarPresident and Head of R&DPurchaseCommon Stock5k$0.68$3.4k 05/16/2023
03/06/2023Session R.A. II10% OwnerOther (acquisition)Common Stock251.3k$0.00$0 03/06/2023
03/06/2023Session R.A. II10% OwnerDispositionEmployee Stock Option (right to buy)199.5k$1.95$389k 03/06/2023
02/02/2023Alam KamranCFOGrantEmployee Stock Option (right to buy)149.9k$1.18$176.9k 02/02/2023
02/02/2023Alam KamranCFOGrantEmployee Stock Option (right to buy)37.4k$1.18$44.1k 02/02/2023
02/02/2023Alam KamranCFOGrantCommon Stock18.7k$0.00$0 02/02/2023
12/30/2022Nolan Sean P.CEOGrantStock Option (right to buy)1.1M$2.26$2.5M 12/30/2022
12/30/2022Nagendran SukumarPresident and Head of R&DGrantStock Option (right to buy)790.1k$2.26$1.8M 12/30/2022
08/23/2022Alam KamranCFOSaleCommon Stock3.3k$3.47$11.5k 08/23/2022
08/22/2022Alam KamranCFOSaleCommon Stock9.7k$3.50$34k 08/18/2022
08/19/2022Alam KamranCFOSaleCommon Stock11.5k$3.75$43.1k 08/18/2022
08/18/2022Alam KamranCFOSaleCommon Stock7.5k$3.87$28.9k 08/18/2022
07/06/2022PRASAD SUYASHCMO and Head of R&DSaleCommon Stock9k$3.79$33.9k 07/05/2022
07/05/2022PRASAD SUYASHCMO and Head of R&DSaleCommon Stock3.9k$3.51$13.7k 07/05/2022
07/01/2022PRASAD SUYASHCMO and Head of R&DSaleCommon Stock23.9k$3.53$84.4k 06/29/2022
06/30/2022PRASAD SUYASHCMO and Head of R&DSaleCommon Stock13.9k$3.72$51.7k 06/29/2022
06/29/2022PRASAD SUYASHCMO and Head of R&DSaleCommon Stock12.3k$3.81$47k 06/29/2022
06/17/2022Sepp-Lorenzino LauraDirectorGrantStock Option (right to buy)15.5k$2.81$43.6k 06/17/2022
06/17/2022Nolan Sean P.CEOGrantStock Option (right to buy)15.5k$2.81$43.6k 06/17/2022
06/17/2022Manning Paul B10% OwnerGrantStock Option (right to buy)15.5k$2.81$43.6k 06/17/2022
06/17/2022Reape KathleenDirectorGrantStock Option (right to buy)15.5k$2.81$43.6k 06/17/2022
06/17/2022Nagendran SukumarPresident and Head of R&DGrantStock Option (right to buy)15.5k$2.81$43.6k 06/17/2022
06/17/2022Donenberg Phillip B.DirectorGrantStock Option (right to buy)15.5k$2.81$43.6k 06/17/2022
04/06/2022Alam KamranCFOGrantEmployee Stock Option (right to buy)40k$6.52$260.8k 04/06/2022
04/06/2022PRASAD SUYASHCMO and Head of R&DGrantEmployee Stock Option (right to buy)40.3k$6.52$262.9k 04/06/2022
02/23/2022PRASAD SUYASHCMO and Head of R&DGrantEmployee Stock Option (right to buy)80.6k$5.96$480.7k 02/23/2022
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy